Dysregulation of ornithine decarboxylase activity, apoptosis and Bcl-2 oncoprotein in Syrian hamster embryo cells stage-exposed to di(2-ethylhexyl)phthalate and tetradecanoylphorbol acetate

Carcinogenesis

Volumn 18, Issue 11, 1997, Pages 2217-2223

  Dhalluin, Stephane ^a   Gate, Laurent ^a   Vasseur, Paule ^b   Tapiero, Haim ^a   Nguyen Ba, Giao ^a  

^a UNIVERSITÉ PARIS SACLAY   (France)

^b Environment Science Centre   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BENZO[A]PYRENE; ORNITHINE DECARBOXYLASE; PHORBOL 13 ACETATE 12 MYRISTATE; PHTHALIC ACID BIS(2 ETHYLHEXYL) ESTER; POLYAMINE; PROTEIN BCL 2; PUTRESCINE; SPERMIDINE; SPERMINE; XENOBIOTIC AGENT;

ANIMAL CELL; APOPTOSIS; ARTICLE; CARCINOGENESIS; CELL DEATH; CELL PROLIFERATION; CELL TRANSFORMATION; CONTROLLED STUDY; EMBRYO; EMBRYO CELL; ENZYME ACTIVITY; ENZYME INDUCTION; GENOTOXICITY; IMMUNOREACTIVITY; NONHUMAN; PRIORITY JOURNAL; SYRIAN HAMSTER;

ANIMALS; APOPTOSIS; CARCINOGENS; CELLS, CULTURED; CRICETINAE; DIETHYLHEXYL PHTHALATE; EMBRYO; MESOCRICETUS; ORNITHINE DECARBOXYLASE; PROTO-ONCOGENE PROTEINS C-BCL-2; TETRADECANOYLPHORBOL ACETATE;

EID: 0031408979     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: 10.1093/carcin/18.11.2217     Document Type: Article

References (53)

1. Wams, T.J. (1987) Diethylhexylphthalate as an environmental contaminant - a review. Sci. Total. Environ., 66, 1-16.
2. Labow, R.S., Meek, E., Adams, G.A. and Rock, G. (1988) Inhibition of human platelet phospholipase A2 by mono(2-ethylhexyl)phthalate. Environ. Health Perspect., 78, 179-183.
3. Mazur, H.I., Stennett, D.J. and Egging, P.K. (1989) Extraction of diethylhexylphthalate from total nutrient solution-containing polyvinyl chloride bags. J. Parenter. Enteral. Nutr., 13, 59-62.
4. Melnick, R.L., Morrissey, R.E. and Tomaszewski, K.E. (1987) Studies by the National Toxicology Program on di(2-ethylhexyl)phthalate. Toxicol. Ind. Health, 3, 99-118.
5. Mullertegethoff, K., Kasper, P. and Muller, L. (1995) Evaluation studies on the in vitro rat hepatocyte micronucleus assay. Mutat. Res., 335, 293-307.
6. Schmezer, P., Pool, B.L., Klein, R.G., Komitowski, D. and Schmahl, D. (1988) Various short-term assays and two long-term studies with the plasticizer di(2-ethylhexyl)phthalate in the Syrian golden hamster. Carcinogenesis, 9, 37-43.
7. Yoshikawa, K. (1996) Anomalous nonidentity between salmonella genotoxicants and rodent carcinogens - nongenotoxic carcinogens and genotoxic noncarcinogens. Environ. Health Perspect., 104, 40-46.
8. Bessi, H., Rast, C., Nguyen-Ba, G., Rether, B. and Vasseur, P. (1995) Synergistic effects of chlordane and TPA in multistage morphological transformation of SHE cells. Carcinogenesis, 16, 237-244.
9. Dhalluin, S., Cruciani, V., Rast, C., Vasseur, P., Tapiero, H. and Nguyen-Ba, G. (1996) Staged exposure of SHE cells to clofibrate and TPA: correlation between morphological transformation, ornithine decarboxylase and metalloprotease activities. Cell. Pharmacol., 3, 23-28.
10. Garvey, L.K., Swenberg, J.A., Hamm, T.E. Jr and Popp, J.A. (1987) Di(2-ethylhexyl)phthalate: lack of initiating activity in the liver of female F-344 rats. Carcinogenesis, 8, 285-290.
11. Elliott, B.M. and Elcombe, C.R. (1987) Lack of DNA damage or lipid peroxidation measured in vivo in the rat liver following treatment with peroxisomal proliferators. Carcinogenesis, 8, 1213-1218.
12. Popp, J.A., Garvey, L.K. and Cattley, R.C. (1987) In vivo studies on the mechanism of di(2-ethylhexyl)phthalate carcinogenesis. Toxicol. Ind. Health, 3, 151-163.
13. Williams, G.M., Maruyama, H. and Tanaka, T. (1987) Lack of rapid initiating, promoting or sequential syncarcinogenic effects of di(2-ethylhexyl)-phthalate in rat liver carcinogenesis. Carcinogenesis, 8, 875-880.
14. Heby, O. (1981) Role of polyamines in the control of cell proliferation and differentiation. Differentiation, 19, 1-20.
15. Okuzumi, J., Yamane, T., Kitao, Y., Tokiwa, K., Yamaguchi, T., Fujita, Y., Nishino, H., Iwashima, A. and Takahashi, T. (1991) Increased mucosal ornithine decarboxylase activity in human gastric cancer. Cancer Res., 51, 1448-1451.
16. Sumiyoshi,H., Baer, A.R. and Wargovich, M.J. (1991) Heterogenicity of ornithine decarboxylase during mouse colon carcinogenesis and in human colon tumors. Cancer Res., 51, 2069-2072.
17. O'Brien, M.J., O'Keane, J.C., Zauber, A., Gottlieb, L.S. and Winawer, S.J. (1992) Precursors of colorectal carcinoma. Biopsy and biologic markers. Cancer, 70, 1317-1327.
18. Nguyen-Ba, G., Dhalluin, S., Elias, Z., Tapiero, H., Poirot, O. and Hornebeck, W. (1993) Overexpression of ornithine decarboxylase and intracellular proteinase in SHE transformed cell line. In Li, F.P. and Montesano, R. (eds) Interactions of Cancer Susceptibility Genes and Environmental Carcinogenesis, AACR and IARC meeting, November 9-13 1993, IARC, Lyon, France.
19. Hibshoosh, H., Johnson, M. and Weinstein, I.B. (1991) Effects of overexpression of ornithine decarboxylase (ODC) on growth control and oncogene-induced cell transformation. Oncogene, 6, 739-743.
20. Auvinen, M., Paasinen, A., Andersson, L.C. and Holtta, E. (1992) Ornithine decarboxylase activity is critical for cell transformation. Nature, 360, 355-358.
21. Shantz, L.M. and Pegg, A.E. (1994) Overproduction of ornithine decarboxylase caused by relief of translational repression is associated with neoplastic transformation. Cancer Res., 54, 2313-2316.
22. Moshier, J.A., Dosescu, J., Skunca, M. and Luk, G.D. (1993) Transformation of NIH/3T3 cells by ornithine decarboxylase overexpression. Cancer Res., 53, 2618-2622.
23. Megosh, L., Gilmour, S.K., Rosson, D., Soler, A.P. Blessing, M., Sawicki, J.A. and Obrien, T.G. (1995) Increased frequency of spontaneous skin tumors in transgenic mice which overexpress ornithine decarboxylase. Cancer Res., 55, 4205-4209.
24. Wrighton, C. and Busslinger, M. (1993) Direct transcriptional stimulation of the ornithine decarboxylase gene by Fos in PC12 cells but not in fibroblasts. Mol. Cell. Biol., 13, 4657-4669.
25. Bello Fernandez, C., Packham, G. and Cleveland, J.L. (1993) The ornithine decarboxylase gene is a transcriptional target of c-Myc. Proc. Natl Acad. Sci. USA, 90, 7804-7808.
26. Auvinen, M., Paasinensohns, A., Hirai, H., Andersson, L.C. and Holtta, E. (1995) Ornithine decarboxylase- and ras-induced cell transformations -reversal by protein tyrosine kinase inhibitors and role of pp130(cas). Mol. Cell. Biol., 15, 6513-6525.
27. McCann, P.P. and Pegg, A.E. (1992) Ornithine decarboxylase as an enzyme target for therapy. Pharmacol. Ther., 54, 195-215.
28. Pegg, A.E., Shantz, L.M. and Coleman, C.S. (1995) Ornithine decarboxylase as a target for chemoprevention. J. Cell. Biochem., 22(Suppl.), 132-138.
29. Quemener, V., Moulinoux, J.P., Havouis, R. and Seiler, N. (1992) Polyamine deprivation enhances antitumoral efficacy of chemotherapy. Anticancer Res., 12, 1447-1454.
30. Kerr, J.F.R., Wyllie, A.H. and Currie, A.R. (1972) Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br. J. Cancer, 26, 239-257.
31. Barr, P.J. and Tomei, L.D. (1994) Apoptosis and its role in human disease. Biotechnology, 12, 487-193.
32. Hale, A.J., Smith, C.A., Sutherland, L.C., Stoneman, V.E.A., Longthorne, V.L., Culhane, A.C. and Williams, G.T. (1996) Apoptosis - molecular regulation of cell death. Eur. J. Biochem., 236, 1-26.
33. Isaacs, J.T. (1993) Role of programmed cell death in carcinogenesis. Environ. Health Perspect., 101 (Suppl. 5), 27-33.
34. Bedi, A., Pasricha, P.J., Akhtar, A.J., Barber, J.P., Bedi, G.C., Giardiello, F.M., Zehnbauer, B.A., Hamilton, S.R. and Jones, R.J. (1995) Inhibition of apoptosis during development of colorectal cancer. Cancer Res., 55, 1811-1816.
35. Lasne, C., Lu, Y.P., Orfila, L., Ventura, L. and Chouroulinkov, I. (1990) Study of various transforming effects of the anabolic agents trenbolone and testosterone on Syrian hamster embryo cells. Carcinogenesis, 11, 541-547.
36. Leboeuf, R.A., Kerckaert, G.A., Aardema, M.J., Gibson, D.P., Brauninger, R. and Isfort, R.J. (1996) The pH 6.7 Syrian hamster embryo cell transformation assay for assessing the carcinogenic potential of chemicals. Mutat. Res., 356, 85-127.
37. Bessi, H., Rast, C., Nguyen-Ba, G. and Vasseur, P. (1994) Chlorothalonil promotes morphological transformation in hamster embryo cells but does not inhibit GAP junctional intercellular communication either in SHE cells or in the V79 cell line. Cancer J., 7, 248-253.
38. Pienta, R.J., Poiley, J.A. and Lebherz III, W.B. (1977) Morphological transformation of early passage golden Syrian hamster embryo cells derived from cryopreserved primary cultures as a reliable in vitro bioassay for identifying diverse carcinogens. Int. J. Cancer, 19, 642-655.
39. Elias, Z., Poirot, O., Pezerat, H. et al. (1989) Cytotoxic and neoplastic transforming effects of industrial hexavalent chromium pigments in Syrian hamster embryo cells. Carcinogenesis, 10, 2043-2052.
40. Nguyen-Ba, G., Robert, S., Dhalluin, S., Tapiero, H. and Hornebeck, W. (1994) Modulatory effect of dexamethasone on ornithine decarboxylase activity and gene expression: a possible post-transcriptional regulation by a neutral metalloprotease. Cell Biochem. Funct., 12, 121-128.
41. Bradford, M. (1976) A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein dye binding. Anal. Biochem., 72, 248-254.
42. Towbin, H., Staehelin, T. and Gordon, J. (1979) Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: Procedure and some applications. Proc. Natl Acad. Sci. USA, 76, 4350-4354.
43. Boyle, C.C. (1996) Divide and rule - non-genotoxic hepatocarcinogens stimulate DNA synthesis and their withdrawal induces apoptosis, but in different hepatocyte populations. Comment. Hum. Exp. Toxicol., 15, 364-366.
44. Schultehermann, R., Bursch, W., Graslkraupp, B., Torok, L., Ellinger, A. and Mullauer, L. (1995) Role of active cell death (apoptosis) in multi-stage carcinogenesis. Toxicol. Lett., 82-83, 143-148.
45. Bayly, A.C., Roberts, R.A. and Dive, C. (1994) Suppression of liver cell apoptosis in vitro by the non-genotoxic hepatocarcinogen and peroxisome proliferator nafenopin. J. Cell Biol., 125, 197-203.
46. Roberts, R.A., Soames, A.R., Gill, J.H., James, N.H. and Wheeldon, E.B. (1995) Non-genotoxic hepatocarcinogens stimulate DNA synthesis and their withdrawal induces apoptosis, but in different hepatocyte populations. Carcinogenesis, 16, 1693-1698.
47. Reddy, J.K. and Lalwai, N.D. (1983) Carcinogenesis by hepatic peroxisome proliferators: evaluation of the risk of hypolipidemic drugs and industrial plasticizers to humans. CRC Crit. Rev. Toxicol., 12, 1-58.
48. Rao, M.S. and Reddy, J.K. (1987) Peroxisome proliferation and hepatocarcinogenesis. Carcinogenesis, 8, 631-636.
49. Kurokawa, Y., Takamura, N., Matushima, Y., Imazawa, T. and Hayashi, Y. (1988) Promoting effect of peroxisome proliferators in two-stage rat renal tumorigenesis. Cancer Lett., 43, 145-149.
50. Hagiwara, A., Tamano, S., Ogiso, T., Asakawa, E. and Fukushima, S. (1990) Promoting effect of the peroxisome proliferator, clofibrate, but not di(2-ethylhexyl)phthalate, on urinary bladder carcinogenesis in F344 rats initiated by N-butyl-N-(4-hydroxybutyl)nitrosamine. Japan. J. Cancer Res., 81, 1232-1238.
51. Richmond, R.E., Carter, J.H., Carter, H.W., Daniel, F.B. and DeAngelo, A.B. (1996) Hepatocyte expression of tumor associated aldehyde dehydrogenase (ALDH-3) and p21 Ras following diethylnitrosamine (DEN) initiation and chronic exposure to di(2-ethylhexyl)phthalate (DEHP). Carcinogenesis, 17, 1647-1655.
52. Cattley, R.C. Kato, M., Popp, J.A., Teets, V.J. and Voss, K.S. (1994) Initiator-specific promotion of hepatocarcinogenesis by WY-14, 643 and clofibrate. Carcinogenesis, 15, 1763-1766.
53. Tsutsui, T., Watanabe, E. and Barrett, J.C. (1993) Ability of peroxisome proliferators to induce cell transformation, chromosome aberrations and peroxisome proliferation in cultured Syrian hamster embryo cells. Carcinogenesis, 14, 611-618.